assist the inexperienced pathologist. Simple tests that identify malignancy and the degree of differentiation would clearly provide valuable information.
Consequently, there has been growing interest among histopathologists about the role of the nucleus, DNA, and cell kinetics in health and disease. DNA flow cytometry, DNA and RNA "in situ" hybridisation, and the use ofthe antibody Ki-67 (which detects a proliferation associated antigen') are among the new techniques that have become available for this purpose. The most recent addition to the list, with possibly one of the simplest applications to current histological practice, is the staining and subsequent study of nucleolar organiser regions.
Abnormalities of the nucleolus have long been known to be a feature of malignant cells.23
Until the advent of electron microscopy, however, nucleolar morphology was of little diagnostic value and consequently of little interest to most histopathologists. The nucleolus has recently been shown to be composed of the relatively electron dense and filamentous nucleolonema and rounded zones of light density and texture known by various names, including pars amorpha, pars fibrosa, and fibrillar centre45 (fig 1) . In interphase these structures are equivalent to nucleolar organiser regions, contain the ribosomal genes, and can be visualised at the ultrastructural and light microscopy levels by the remarkably selective staining of their associated proteins by a silver colloid technique.6 At the light microscopy level nucleolar organiser regions appear as small black dots when stained in this way, known as AgNORs.
Over the past three years numerous pathological and clinical reports have documented new applications of this simple method. The purpose of this review is to give an account of the theoretical and practical basis of the study of nucleolar organiser regions and to document its application to histopathological practice with special reference to the respiratory tract. Soosay and colleagues' found some overlap, however, and considered the case for routine use of the AgNOR method in individual problems to be unproved. In (unpublished) work comparing pleural aspirates, pleural biopsy, and follow up postmortem examination we have found the AgNOR method to be a useful adjunct to established methods, though it does not distinguish between adenocarcinoma and mesothelioma ( fig 5) . A raised AgNOR score can differentiate malignant pleural disease from benign disease.
Small cell carcinoma of the bronchus may also be a diagnostic problem, especially in small biopsy samples obtained at bronchoscopy, where its distinction from other tumours and from aggregates of lymphocytes may be difficult. Enumeration of AgNOR sites has afforded diagnostically useful data in this context. Lymphoid specimens contain less than two AgNORs per cell, whereas small cell carcinoma cells contain over four' (fig 6) . The values in the two conditions were so widely separated that formal counting was considered unnecessary. The caveat is that low grade non-Hodgkin's lymphoma could not be distinguished from benign lymphocytes and consequently other methods would have to be used to ensure that the former was not present.' None the less, the usefulness of the method in the diagnosis of small cell carcinoma is apparent.
The reproducibility ofthe method has recently been shown by Benbow The immediate conclusion to be drawn from these studies is that AgNOR numbers in some h way reflect or even direct cell proliferation.
Morphometric analysis of highly magnified -* photomicrographs has also proved to be of use in that high and low grade non-Hodgkin's lymphomas show wide separation of the diameter and area of the AgNORs. 
Conclusions
Over the past three years numerous publications have helped to show the usefulness of AgNOR enumeration. The argyrophil technique is remarkably specific for proteins associated with nucleolar organiser regions and a simple and a standardised approach has allowed correlation of data within and between laboratories. Relatively few prognostic studies have been carried out, and benign and malignant conditions in some studies have a considerable overlap of AgNOR numbers.3254556'
The method at present cannot distinguish between physiological and neoplastic proliferation in certain lesions-a failure shared with other innovative techniques in tumour pathology, notably immunolabelling with Ki 67 and DNA flow cytometry. Nevertheless, the initial promise of the method has been fulfilled in many areas. The technique has found use, for example, in neoplasms of skin,44 46 28 Interesting and potentially useful information has been provided for many types of neoplasms, including certain canine tumours.79 These suggest that nucleolar organiser regions reflect or even direct cell proliferation, and the numbers may reflect complex cellular and nuclear interactions, including gene amplification.
Future studies using antibodies to nucleolar organiser regions and their associated proteins or other probes should elucidate their role in the transformation of tumour cells, and explain the ectopic situation of some AgNORs outside nucleolar structures. It is hoped that such studies will also provide further diagnostic applications.
